[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PE20070182A1 - Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona - Google Patents

Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona

Info

Publication number
PE20070182A1
PE20070182A1 PE2006000916A PE2006000916A PE20070182A1 PE 20070182 A1 PE20070182 A1 PE 20070182A1 PE 2006000916 A PE2006000916 A PE 2006000916A PE 2006000916 A PE2006000916 A PE 2006000916A PE 20070182 A1 PE20070182 A1 PE 20070182A1
Authority
PE
Peru
Prior art keywords
phenyl
alkyl
cyanopyrrol
progesterone receptor
amide derivatives
Prior art date
Application number
PE2006000916A
Other languages
English (en)
Inventor
Casey Cameron Mccomas
Andrew Fensome
Edward George Melenski
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20070182A1 publication Critical patent/PE20070182A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE REFIERE A DERIVADOS CIANOPIRROL-FENIL AMIDA DE FORMULA (I), EN DONDE R1 ES H, CN, C(O)-ALQUILO(C1-C6), C(O)-CICLOALQUILO(C3-C8), C(O) NALQUILO, ENTRE OTROS O R1 ES UN GRUPO DE UNION C(O) A UNA SEGUNDA ESTRUCTURA DE FORMULA (I) PARA FORMAR UN DIMERO DEL MISMO; R2 ES H, ALQUILO(C1-C6), CICLOALQUILO(C3-C6), ENTRE OTROS; R3, R4, R5 Y R6 SON INDEPENDIENTEMENTE H, HALOGENO, ALQUILO(C1-C6), ENTRE OTROS; R7 ES H, ALQUILO(C1-C6), CICLOALQUILO(C3-C6); ENTRE OTROS. SON PREFERIDOS: N-[4-(5-CIANO-1-METIL-1H-PIRROL-2-IL)FENIL]-2-FURAMIDA, N-[4-(5-CIANO-1-METIL-1H-PIRROL-2IL)FENIL]-3-METILBUTANAMIDA, N-[4-(5-CIANO-1-METIL-1H-PIRROL-2-IL)FENIL]-2-METILPROPANAMIDA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA OPCINALMENTE EN COMBINACION CON UNA PROGESTINA O ESTROGENO Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON MODULADORES DEL RECEPTOR DE PROGESTERONA (RP) POR LO QUE SON UTILES PARA LA CONTRACEPCION Y TERAPIA DE REEMPLAZO HORMONAL
PE2006000916A 2005-07-29 2006-07-26 Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona PE20070182A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70400805P 2005-07-29 2005-07-29

Publications (1)

Publication Number Publication Date
PE20070182A1 true PE20070182A1 (es) 2007-03-06

Family

ID=37309008

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000916A PE20070182A1 (es) 2005-07-29 2006-07-26 Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona

Country Status (13)

Country Link
US (2) US7297713B2 (es)
EP (1) EP1910284A1 (es)
JP (1) JP2009502946A (es)
CN (1) CN101233103A (es)
AR (1) AR055590A1 (es)
AU (1) AU2006275832A1 (es)
BR (1) BRPI0614413A2 (es)
CA (1) CA2613484A1 (es)
GT (1) GT200600335A (es)
MX (1) MX2008001337A (es)
PE (1) PE20070182A1 (es)
TW (1) TW200728274A (es)
WO (1) WO2007016211A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070182A1 (es) * 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
PE20070341A1 (es) * 2005-07-29 2007-04-13 Wyeth Corp Derivados de pirrol como moduladores del receptor de progesterona
TW200848021A (en) * 2007-03-06 2008-12-16 Wyeth Corp Sulfonylated heterocycles useful for modulation of the progesterone receptor
TW200848019A (en) * 2007-03-06 2008-12-16 Wyeth Corp Aryl sulfonamides useful for modulation of the progesterone receptor
EA201070715A1 (ru) * 2007-12-20 2011-02-28 Тева Вимен'С Хелс, Инк. Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции
BRPI1003661A2 (pt) * 2010-09-15 2013-01-08 Libbs Farmaceutica Ltda associaÇço farmacÊutica para tratar e/ou prevenir mioma e/ou endometriose, uso de resveratrol e progestogenio, composiÇço farmacÊutica para tratamento e/ou prevenÇço de mioma e/ou endometriose medicamento para tratamento e/ou prevenÇço de mioma e/ou endometrios, kit e mÉtodo para tratamento e/ou prevenÇço de mioma e/ou endometriose
ES2712211T3 (es) 2013-06-20 2019-05-09 Bayer Cropscience Ag Derivados de arilsulfuro y arilsulfóxido acaricidas e insecticidas

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1051322A (es) 1967-08-09
GB1215858A (en) 1968-05-03 1970-12-16 Merck & Co Inc Nitroimidazole derivatives
EP0003640B1 (en) 1978-01-18 1982-01-27 Imperial Chemical Industries Plc Antisecretory guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
DE3168754D1 (en) 1980-07-09 1985-03-21 Beecham Group Plc Clonidine derivatives useful in the treatment of diarrhoea
US4680413A (en) 1986-01-17 1987-07-14 Nippon Soda Co., Ltd. Process for the production of 3-phenyl-4-cyanopyrroles
US4857651A (en) 1987-07-29 1989-08-15 American Cyanamid Company α-(2,3-Di(C1 -C4 alkoxy)ethylamino)-β-cyanostyrene and β-nitrostyrene compounds useful as intermediates in the preparation of insecticidal, acaricidal and nematicidal arylpyrroles and method for the preparation thereof
US5455263A (en) 1987-07-29 1995-10-03 American Cyanamid Company Methods for the control and the protection of warm-blooded animals against infestation and infection by helminths, acarids and arthropod endo- and ectoparasites
US4929634A (en) 1987-10-23 1990-05-29 American Cyanamid Company Method of and bait compositions for controlling mollusks
DE3814057A1 (de) 1988-04-26 1989-11-09 Heumann Pharma Gmbh & Co 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0358047A3 (en) 1988-09-08 1991-05-29 American Cyanamid Company Method of controlling phytopathogenic fungi
GB8903592D0 (en) 1989-02-16 1989-04-05 Boots Co Plc Therapeutic agents
DK0426948T3 (da) 1989-08-11 1996-05-28 American Cyanamid Co Arylpyrroler som insekticide, acaricide og nematodicide midler samt fremgangsmåder til deres fremstilling
DE69110003T2 (de) 1990-05-11 1996-02-22 American Cyanamid Co N-acylierte Arylpyrrole als insektizide, akarizide, nematizide und molluskizide Wirkstoffe.
US5328928A (en) 1990-05-11 1994-07-12 American Cyanamid Company N-acylated arylpyrroles useful as insecticidal, agents
IN172842B (es) 1990-05-17 1993-12-11 Boots Pharmaceuticals Limited
US5210092A (en) 1990-09-25 1993-05-11 Fujisawa Pharmaceutical Co., Ltd. Angiotensin ii antagonizing heterocyclic derivatives
US5215994A (en) 1990-09-25 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Angiotenin II antagonizing heterocyclic derivatives
DE4036645A1 (de) 1990-11-16 1992-05-21 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung
US5151536A (en) 1990-12-17 1992-09-29 American Cyanamid Company Process for the manufacture of pesticidal 1-(alkoxymethyl) pyrrole compounds
DE4102024A1 (de) 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5847006A (en) 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
WO1993019067A1 (en) 1991-09-12 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine derivatives as angiotensin ii antagonists
GB9201789D0 (en) 1992-01-28 1992-03-11 Fujisawa Pharmaceutical Co Heterocyclic derivatives
US5354759A (en) 1991-09-12 1994-10-11 Fujisawa Pharmaceutical Co., Ltd. Angiotenin II antagonizing heterocyclic compounds
US5284863A (en) 1991-12-04 1994-02-08 American Cyanamid Company Haloalkylthio, -sulfinyl and -sulfonyl arylpyrrole fungicidal agents
US5306827A (en) 1991-12-04 1994-04-26 American Cyanamid Company Haloalkylthio, -sulfinyl and -sulfonyl arylpyrrole insecticidal and acaricidal agents
GB9202633D0 (en) 1992-02-07 1992-03-25 Fujisawa Pharmaceutical Co Heterocyclic derivatives
GB9217820D0 (en) 1992-08-21 1992-10-07 Fujisawa Pharmaceutical Co New use
US5449789A (en) 1992-11-30 1995-09-12 American Cyanamid Company Debrominative chlorination of pyrroles
US5518891A (en) 1993-03-25 1996-05-21 Actimed Laboratories, Inc. Dye forming composition and detection of hydrogen peroxide therewith
TW283246B (es) * 1994-02-17 1996-08-11 Mitsubishi Electric Machine
WO1995022520A1 (en) 1994-02-17 1995-08-24 American Home Products Corporation Substituted biphenyl derivatives as phosphodiesterase inhibitors
US20010020100A1 (en) 1994-06-14 2001-09-06 G.D. Searle & Co. N-substituted-1, 2, 4-triazolone compounds for treatment of cardiovascular disorders
DE19515177A1 (de) 1995-04-28 1996-10-31 Cassella Ag Hydantoinderivate als Zwischenprodukte für pharmazeutische Wirkstoffe
PT828728E (pt) 1995-05-18 2003-06-30 Altana Pharma Ag Di-hidrobenzofuranos de fenilo
US5932520A (en) 1995-05-23 1999-08-03 American Cyanamid Company Use of pyrrole compounds as antifouling agents
CZ293077B6 (cs) 1996-08-02 2004-02-18 American Cyanamid Company Stabilní arylpyrrolové částice, způsob jejich přípravy a kompozice tvořené suspenzním koncentrátem, obsahující tyto částice
US6242613B1 (en) 1996-08-02 2001-06-05 American Cyanamid Co. Stable arylpyrrole particles, process for their preparation and suspension concentrate compositions comprising them
EP1019047B1 (en) 1997-05-01 2003-11-05 Eli Lilly And Company Antithrombotic agents
SG72827A1 (en) 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
TW460460B (en) 1997-11-04 2001-10-21 Chugai Pharmaceutical Co Ltd Heterocyclic compounds having NOS inhibitory activities
AUPP873799A0 (en) 1999-02-17 1999-03-11 Fujisawa Pharmaceutical Co., Ltd. Pyridine compounds
CA2368631A1 (en) 1999-03-26 2000-10-05 Euro-Celtique S.A. Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
DE19918725A1 (de) 1999-04-24 2000-10-26 Bayer Ag Substituierte N-Cyano-sulfonsäureanilide
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6403629B2 (en) 2000-05-02 2002-06-11 J.B. Chemical And Pharmaceuticals Limited Heterocyclic compounds for therapeutic use
CN1496366A (zh) 2001-03-09 2004-05-12 �Ʒ� 作为抗炎剂的三唑并吡啶
DE60207390T2 (de) 2001-03-09 2006-07-20 Pfizer Products Inc., Groton Entzündungshemmende benzimidazolverbindungen
ATE304009T1 (de) 2001-04-04 2005-09-15 Pfizer Prod Inc Neue benzotriazole mit entzündungshemmender wirkung
ITBO20010271A1 (it) 2001-05-08 2002-11-08 Giuseppe Cannazza Metodo per il trattamento e la prevenzione dei disturbi del sistema nervoso centrale associati ad una alterazione della neurotrasmissione gl
FR2824827B1 (fr) 2001-05-17 2004-02-13 Fournier Lab Sa Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8
US6855269B2 (en) 2001-11-09 2005-02-15 Cytec Technology Corp. Phenyl ether-substituted hydroxyphenyl triazine ultraviolet light absorbers
US7119203B2 (en) 2002-04-25 2006-10-10 Pharmacia Corporation Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
AU2003278927A1 (en) 2002-09-27 2004-04-19 Janssen Pharmaceutica N.V. 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases
WO2004039795A2 (en) 2002-10-29 2004-05-13 Fujisawa Pharmaceutical Co., Ltd. Amide compounds for the treatment of hyperlipidemia
CA2505361A1 (en) 2002-11-11 2004-05-27 Bayer Healthcare Ag Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
GB0230088D0 (en) 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0302671D0 (en) 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
WO2004073594A2 (fr) 2003-02-12 2004-09-02 L'oreal Utilisation d’un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres
PL1756095T3 (pl) * 2004-04-27 2008-10-31 Wyeth Corp Cyjanopirole zawierające cykliczne karbaminianowe i tiokarbaminianowe biaryle oraz sposoby ich wytwarzania
GT200500183A (es) 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
GT200500185A (es) 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
PE20070341A1 (es) 2005-07-29 2007-04-13 Wyeth Corp Derivados de pirrol como moduladores del receptor de progesterona
PE20070404A1 (es) 2005-07-29 2007-05-10 Wyeth Corp Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesterona
PE20070182A1 (es) 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona

Also Published As

Publication number Publication date
EP1910284A1 (en) 2008-04-16
GT200600335A (es) 2007-05-28
CN101233103A (zh) 2008-07-30
CA2613484A1 (en) 2007-02-08
US7652062B2 (en) 2010-01-26
US20070027125A1 (en) 2007-02-01
AR055590A1 (es) 2007-08-29
AU2006275832A1 (en) 2007-02-08
JP2009502946A (ja) 2009-01-29
BRPI0614413A2 (pt) 2016-11-22
US20080064673A1 (en) 2008-03-13
US7297713B2 (en) 2007-11-20
TW200728274A (en) 2007-08-01
MX2008001337A (es) 2008-03-25
WO2007016211A1 (en) 2007-02-08

Similar Documents

Publication Publication Date Title
PE20070182A1 (es) Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
PE20070341A1 (es) Derivados de pirrol como moduladores del receptor de progesterona
PE20080997A1 (es) Compuestos n-fenilmetil-5-oxo-prolina-2-amida como moduladores de receptores p2x7
PE20220597A1 (es) Inhibidores de la autofagia de fenilaminopirimidina amida y metodos de uso de estos
PE20070642A1 (es) Compuestos derivados de pirazol como antagonistas del receptor de la progesterona
PE20070112A1 (es) Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos
PE20071095A1 (es) Derivados policiclicos de indazol como inhibidores de erk
AR049706A1 (es) Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
NO20063470L (no) Tetrazolforbindelser og deres anvendelse av metabotrofe glutamatreseptorantagonister
PE20090890A1 (es) Compuestos derivados de 1-(2,3-dihidrobenzo[1,4]dioxin-2-ilmetil)azaciclos como antagonistas del suptipo adrenoreceptor alfa2c
PE20071245A1 (es) COMPUESTOS INDOL SULFONAMIDA COMO MODULADORES DEL RECEPTOR DE PROGESTERONA SELECTIVOS (SPRMs)
AR049708A1 (es) Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
TW200716137A (en) Tanaproget compositions containing ethinyl estradiol
PE20061084A1 (es) Compuestos derivados de 2-ciano-3-(halo)alcoxi-bencenosulfonamida
PE20091724A1 (es) Derivados de indol como moduladores del receptor nicotinico de acetilcolina alfa 7
PE20080704A1 (es) Inhibidores ns5b del virus hepatitis c de indolobenzazepina fusionados a ciclopropilo
PE20011371A1 (es) Derivados de 3-(3-isopropil-5-metil-4h-1,2,4-triazol-4-il)-exo-8-azabiciclo[3.2.1]octano como antagonistas de los receptores de quimiocina ccr5
PE20060401A1 (es) Derivados de n-(2-bencil)-2-fenil-butanamidas y propanamidas como moduladores del receptor de androgeno
PE20090741A1 (es) Derivados de 1,1,1-trifluor-2-hidroxi-3-fenilpropano
PE20061316A1 (es) Derivados de pirazol como antagonistas del receptor de progesterona
AR061656A1 (es) Compuesto de bencilpiperazina, su uso para preparar un medicamento, composicion farmaceutica que lo comprende y procesos para la preparacion de la composicion y del compuesto
PE20081831A1 (es) Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona
NO20076060L (no) Piperidin-4-yl-amidderivater og deres anvendelse som SST-reseptor subtype 5-antagonister
PE20060590A1 (es) COMPUESTOS ESTEROIDALES 15ß-SUSTITUIDOS CON ACTIVIDAD SELECTIVA DEL RECEPTOR DE ESTROGENOS
MY142048A (en) Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal